Author contributions
AG: Designed study, wrote study protocol, developed cell product and manufacturing protocol, wrote IB, recruited patients, analyzed data, generated figures, wrote manuscript. RG: Developed manufacturing protocol, wrote IB, performed quality analysis of the cell product, performed manufacturing, analyzed data, generated figures. MA: Designed study, wrote IB, developed manufacturing protocol, wrote manuscript. AMo: Designed study, designed peptide pools, analyzed data, wrote manuscript. AK: Recruited patient as principal investigator at University Hospital of Erlangen, helped analyzing data, helped writing manuscript. CS: Recruited patients as principal investigator at University Hospital of Augsburg. KH: Recruited patients as principal investigator at University Hospital of Augsburg. EW: Recruited patients as principal investigator at University Hospital Mainz. BH: Recruited patients at University Hospital Mainz. DT: Recruited patients at University Hospital Mainz. WR: Recruited patient as principal investigator at University Hospital of Erlangen. BS: Recruited patient as co-principal investigator at University Hospital of Erlangen. JT: Recruited patient as principal investigator at University Hospital of Munich. SMo: Manufactured T cell products, performed quality analysis of products. HB: Manufactured T cell products, helped in quality analysis. SS: Manufactured T cell products, helped in quality analysis. JBa: Manufactured T cell products, helped in quality analysis. AW: Coordinated logistics and communication with donor centers. Organized transportation of products and raw material. FS: Coordinated logistics and communication with donor centers. Organized transportation of products and raw material. Helped consenting patients at University Hospital Erlangen. Applied products. JBr: Recruited and consented patients at Charite University Hospital Berlin. BU: Designed secuTrial ECRF and VigilanceOne™ database. Prepared and analyzed data. SMa: Designed study, helped writing study protocol and IB, communicated with authorities, performed data analysis and submission. SH: Designed study, helped writing study protocol and IB, communicated with authorities, performed data analysis and submission. Performed pharmacovilgilance. JS: Supervised manufacturing and quality analysis, performed product release. RZi: Helped writing IB, supervised manufacturing and quality analysis, performed product release. VW: Supervised manufacturing and quality analysis, performed product release. LH: Recruited patients at Charite University Hospital Berlin, analyzed data, helped writing manuscript. FL-C: Analyzed data, analyzed T cell products, performed patient follow up analysis at Charite University Hospital Berlin. MR: performed statistical analysis, helped analyzing data. MS: Served as member of the Data Safety Monitoring Board. FA: Served as member of the Data Safety Monitoring Board. RZe: Served as member of the Data Safety Monitoring Board. AMa: Designed study, wrote study protocol, recruited patients, analyzed data, wrote manuscript. All authors contributed to the article and approved the submitted version.